Zhi Yang Ng
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zhi Yang Ng.
Annals of Surgery | 2017
Curtis L. Cetrulo; Kai Li; Harry M. Salinas; Matthew Treiser; Ilse Schol; Glen W. Barrisford; Francis J. McGovern; Adam S. Feldman; Michael T. Grant; Cigdem Tanrikut; Jeffrey H. Lee; Richard J. Ehrlichman; Paul W. Holzer; Garry Choy; Raymond W. Liu; Zhi Yang Ng; Alexandre G. Lellouch; John M. Kurtz; Austen Wg; Jonathan M. Winograd; Branko Bojovic; Kyle R. Eberlin; Ivy A. Rosales; Robert B. Colvin; Dicken S.C. Ko
Objective: We describe the first successful penis transplant in the United States in a patient with a history of subtotal penectomy for penile cancer. Background: Penis transplantation represents a new paradigm in restoring anatomic appearance, urine conduit, and sexual function after genitourinary tissue loss. To date, only 2 penis transplants have been performed worldwide. Methods: After institutional review board approval, extensive medical, surgical, and radiological evaluations of the patient were performed. His candidacy was reviewed by a multidisciplinary team of surgeons, physicians, psychiatrists, social workers, and nurse coordinators. After appropriate donor identification and recipient induction with antithymocyte globulin, allograft procurement and recipient preparation took place concurrently. Anastomoses of the urethra, corpora, cavernosal and dorsal arteries, dorsal vein, and dorsal nerves were performed, and also inclusion of a donor skin pedicle as the composite allograft. Maintenance immunosuppression consisted of mycophenolate mofetil, tacrolimus, and methylprednisolone. Results: Intraoperative, the allograft had excellent capillary refill and strong Doppler signals after revascularization. Operative reinterventions on postoperative days (PODs) 2 and 13 were required for hematoma evacuation and skin eschar debridement. At 3 weeks, no anastomotic leaks were detected on urethrogram, and the catheter was removed. Steroid resistant-rejection developed on POD 28 (Banff I), progressed by POD 32 (Banff III), and required a repeat course of methylprednisolone and antithymocyte globulin. At 7 months, the patient has recovered partial sensation of the penile shaft and has spontaneous penile tumescence. Our patient reports increased overall health satisfaction, dramatic improvement of self-image, and optimism for the future. Conclusions: We have shown that it is feasible to perform penile transplantation with excellent results. Furthermore, this experience demonstrates that penile transplantation can be successfully performed with conventional immunosuppression. We propose that our successful penile transplantation pilot experience represents a proof of concept for an evolution in reconstructive transplantation.
Clinics in Plastic Surgery | 2017
Curtis L. Cetrulo; Zhi Yang Ng; Jonathan M. Winograd; Kyle R. Eberlin
Modern microsurgical techniques have made possible a broad spectrum of novel means for the reconstruction of complex bone and soft tissue defects. These techniques, in combination with developments in transplant immunology, have led to successful hand and facial allotransplantation and achievement of the highest rung in the reconstructive ladder - truly replacing like with like. The utilization of contemporary microsurgical technique in the context of vascularized composite allotransplantation (VCA) (1) permits successful technical execution and feasibility of VCA, (2) facilitates the study of immunologic tolerance in VCA preclinical models, and (3) optimizes functional VCA outcomes.
Archives of Plastic Surgery | 2017
Zhi Yang Ng; Shaun Shi Yan Tan; Alexandre G. Lellouch; Curtis L. Cetrulo; Harvey W. Chim
Background Upper extremity soft tissue defects with complete circumferential involvement are not common. Coupled with the unique anatomy of the upper extremity, the underlying etiology of such circumferential soft tissue defects represent additional reconstructive challenges that require treatment to be tailored to both the patient and the wound. The aim of this study is to review the various options for soft tissue reconstruction of complete circumferential defects in the upper extremity. Methods A literature review of PubMed and MEDLINE up to December 2016 was performed. The current study focuses on forearm and arm defects from the level at or proximal to the wrist and were assessed based on Tajimas classification (J Trauma 1974). Data reviewed for analysis included patient demographics, causality, defect size, reconstructive technique(s) employed, and postoperative follow-up and functional outcomes (when available). Results In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 14 unique articles were identified for a total of 50 patients (mean=28.1 years). Underlying etiologies varied from extensive thermal or electrical burns to high impact trauma leading to degloving or avulsion, crush injuries, or even occur iatrogenically after tumor extirpation or extensive debridement. Treatment options ranged from the application of negative pressure wound dressings to the opposite end of the spectrum in hand transplantation. Conclusions With the evolution of reconstructive techniques over time, the extent of functional and aesthetic rehabilitation of these complex upper extremity injuries has also improved. The proposed management algorithm comprehensively addresses the inherent challenges associated with these complex cases.
Vascularized Composite Allotransplantation | 2015
Zhi Yang Ng; Charlotte Read; Josef M Kurtz; Curtis L. Cetrulo
Memory T cells are generated as part of the bodys primary immune response to infection and environmental exposure so that a primed and more rapid response can be mounted in subsequent encounters. While beneficial in response to subsequent pathogen exposures, the unique characteristics of memory T cells such as their longevity, distinct trafficking patterns to multiple body sites, and cross-reactivity with donor antigens, have been demonstrated to represent a formidable barrier to successful transplantation and tolerance induction in both animal research models and clinical studies. In the context of vascularized composite allotransplantation (VCA) where acute rejection episodes are frequent despite chronic immunosuppression, current research efforts are directed toward immunosuppression minimization or complete withdrawal of immunosuppression through the attainment of transplantation tolerance. This review focuses on the potential roles of memory T cells on the rejection process at the level of the skin and the outcome of immunologic protocols for tolerance induction in VCA.
Journal of Craniofacial Surgery | 2017
Zhi Yang Ng; Kyle R. Eberlin; Tianyu Lin; Peter T. Masiakos; Curtis L. Cetrulo
Abstract Dog bite injuries are common and the head and neck is most frequently involved in pediatric patients. In severe cases, the combination of crushing, tearing, and puncturing can result in scalp avulsion. Currently, microsurgical replantation of the avulsed scalp remains the gold standard but may not always be possible. The authors present their treatment algorithm with 2 patient examples. In Patient 1, the scalp was deemed unsuitable for replantation due to extensive soft tissue injury; in Patient 2, the scalp was not available on presentation. Both patients underwent debridement and early wound coverage followed by multistage secondary revision through serial tissue expansion and excision. At 3-years follow-up, both patients have achieved satisfactory aesthetic outcomes following the initial loss of 70% and 40% of hair-bearing scalp. There were no infective complications or wound dehiscence and the areas of scar alopecia are much improved with preservation of the hairline. Pediatric scalp avulsion injuries resulting from dog bites are uncommon and involve a unique injury mechanism. Coupled with the diminutive size of vessels in this patient population, replantation may be precluded altogether. A delayed and staged approach to reconstruction can restore a hair-bearing scalp for satisfactory outcomes.
Journal of Burn Care & Research | 2017
Paul W. Holzer; David A. Leonard; Kumaran Shanmugarajah; Krysta N. Moulton; Zhi Yang Ng; Curtis L. Cetrulo; David H. Sachs
The clinical use of frozen, human allogeneic skin grafts is considered a suitable alternative to freshly harvested allogeneic skin grafts when the latter are not available. However, limited functional and histological information exists regarding the effects of cryopreservation on allogeneic skin grafts, especially those across mismatched histocompatibility barriers. Thus, we performed a side-by-side comparative study of fresh vs frozen skin grafts, across both minor and major histocompatibility barriers, in a miniature swine model. Since porcine skin shares many physical and immunological properties with human skin, our findings have relevance to current clinical practices involving allogeneic grafting and may support future, temporary wound therapies involving frozen xenografts, comprised genetically modified porcine skin. Four miniature swine underwent harvest and grafting of split-thickness skin, with and without cryopreservation, in order to observe autologous grafts and grafts across minor and major histocompatibility barriers. A biopsy of the grafts was done at regular intervals for study of architecture, vascularization, and outcomes. All grafts vascularized without technical complications. Differences were noted in the early appearance of some fresh vs frozen grafts, but no significant difference was observed in overall survival times in any of the experimental groups. These results demonstrate that despite early observable differences in the healing process, cryopreservation and thawing does not significantly affect long-term graft survival or time to rejection, thus supporting the clinical and experimental use of fresh and frozen split-thickness skin grafts as comparable and interchangeable.
Journal of Burn Care & Research | 2017
Melissa Mastroianni; Zhi Yang Ng; Ritu Goyal; Christopher Mallard; Evan A. Farkash; David A. Leonard; Alexander Albritton; Kumaran Shanmugarajah; John M. Kurtz; David H. Sachs; Lauren K. Macri; Joachim Kohn; Curtis L. Cetrulo
Abstract Cadaveric skin allograft is the current standard of treatment for temporary coverage of large burn wounds. Porcine xenografts are viable alternatives but undergo α-1,3-galactose (Gal)–mediated hyperacute rejection and are lost by post-operative day (POD) 3 because of naturally occurring antibodies to Gal in primate recipients. Using baboons, we previously demonstrated that xenografts from GalT-KO swine (lacking Gal) provided wound coverage comparable with allografts with systemic immunosuppression. In this study, we investigate topical immunosuppression as an alternative to prolong xenograft survival. Full-thickness wounds in baboons were created and covered with xenogeneic and allogeneic split-thickness skin grafts (STSGs). Animals were treated with slow-release (TyroSphere-encapsulated) topical formulations (cyclosporine-A [CSA] or Tacrolimus) applied 1) directly to the STSGs only, or 2) additionally to the wound bed before STSG and 1). Topical CSA did not improve either xenograft or allograft survival (median: treated grafts = 12.5 days, control = 14 days; P = 0.27) with similar results when topical Tacrolimus was used. Pretreatment of wound beds resulted in a significant reduction of xenograft survival compared with controls (10 vs 14 days; P = 0.0002), with comparable results observed in allografts. This observation was associated with marked reduction of inflammation on histology with Tacrolimus and not CSA. Prolongation of allograft and xenograft survival after application to full-thickness wound beds was not achieved with the current formulation of topical immunosuppressants. Modulation of inflammation within the wound bed was effective with Tacrolimus pretreatment before STSG application and may serve as a treatment strategy in related fields.
Vascularized Composite Allotransplantation | 2016
Zhi Yang Ng; Matthew W. Defazio; Harrison Powell; David A. Leonard; Zachary W. Heroux; Alexandre G. Lellouch; Ilse Schol; John M. Kurtz; Curtis L. Cetrulo
BackgroundFollowing face or hand transplantation, maintenance immunosuppression is required to prevent VCA loss However, despite such immunosuppression, up to 85% of patients develop at least an ep...
Vascularized Composite Allotransplantation | 2016
Zhi Yang Ng; Alexandre G. Lellouch; Matthew W. Defazio; Zachary W. Heroux; Ilse Schol; John M. Kurtz; Curtis L. Cetrulo
2552: Toward tolerance of facial allotransplantation: Preliminary results in a non-human primate model with tocilizumab Zhi Yang Ng, MD, Alexandre G. Lellouch, MD, Matthew W. Defazio, BS, Zachary W. Heroux, BS, Ilse Schol, BS, Josef M. Kurtz, PhD, and Curtis L. Cetrulo, Jr., MD, FACS, FAAP Massachusetts General Hospital, Boston, MA, USA Background Tocilizumab (anti-IL-6 receptor mAb) is currently FDA approved for use in idiopathic and rheumatoid arthritis. It mitigates inflammation, reduces the incidence of GvHD, and promotes regulatory T-cell proliferation We investigated its utility in a non-human primate model (NHP) of facial VCA to achieve prolonged survival and/or tolerance in reconstructive transplantation. Methods Facial allografts were transplanted into MHC-mismatched NHPs (n D 4) after ATGAM induction, maintained post-operatively with FK506, MMF and methylprednisolone, before further conditioning (irradiation, lymphocyte depletion) in preparation for donor bone marrow transplantation (DBMT) on POD 60 Tocilizumab was administered on the day of DBMT, and at weekly intervals thereafter for a total of 5 doses Post-DBMT, recipients received a tapering course of cyclosporine-A with complete withdrawal 28 d later VCA was assessed by serial clinical examination and histopathology; chimerism was monitored by flow cytometry and in vitro immunologic responses were measured with CFSE mixed lymphocyte reaction (MLR) assays. Results Prior to DBMT, up to 2 episodes of acute skin rejection (AR) developed and required additional steroid bolus treatment Two recipients had to be euthanized within 2 weeks post-DBMT due to lung infection from neutropenic sepsis and disseminated post-transplant lymphoproliferative disorder (PTLD) respectively but VCAs remained AR-free up to experimental end point Of the remaining 2 recipients, one has just been withdrawn from immunosuppression while the other was off for 36 d before AR developed No evidence of mixed chimerism was detected but in vitro assays demonstrate decreased anti-donor responses after DBMT, which remains up to this time To date, no systemic sequelae of GvHD or PTLD have been observed at up to POD 205. Conclusions As with the clinical experience in patients treated with tocilizumab, vigilant monitoring is required following drug administration due to increased susceptibility to infection and neutropenia Anti-IL-6 blockade appears to promote shortmedium term immunosuppression-free VCA survival in this NHP model Continued follow-up is required to determine if long-term transplantation tolerance of the VCA has been achieved Of particular clinical concern is the development of PTLD following tolerance induction Further investigations are underway to optimize and develop a safe VCA tolerance protocol for clinical application. CONTACT Zhi Yang Ng [email protected]
Plastic and reconstructive surgery. Global open | 2016
Alexandre G. Lellouch; Negin Karimian; Zhi Yang Ng; Safak Mert; Sharon Geerts; Korkut Uygun; Curtis L. Cetrulo
2517: Ex-vivo subnormothermic oxygenated machine perfusion of swine forelimbs enables prolonged graft preservation prior to transplantation Alexandre Gaston Lellouch, Negin Karimian, Zhi Yang Ng, Safak Mert, Sharon Geerts, Korkut Uygun, and Curtis L. Cetrulo Harvard University, Boston, MA, USA; Massachusetts General Hospital, Boston, MA, USA Background The current gold standard in tissue preservation is static cold storage (SCS) on ice-cold (0–4 C) UW solution. While SCS slows down graft deterioration, it does not have restorative capabilities. We previously developed an ex-vivo perfusion system for subnomothermic oxygenated machine perfusion (SNMP) to resuscitate cadaveric organs. Recovered livers were perfused for 3 hours and transplanted successfully into recipient rats in 5/6 cases; when scaled up to DCD human livers, SNMP demonstrated sustained and enhanced viability of liver grafts. To expand the donor pool in VCA, we investigated the utility of SNMP on preservation time and resuscitation of ischemic limbs in a swine model. Methods 2 porcine forelimbs were procured and flushed with ice-cold UW on the back table through the cannulated axillary artery and veins. Warm ischemia was 45 mins and SCS was 2 hours. Before starting SNMP, the forelimbs were flushed with 1500 mL of cold Lactated Ringers. During SNMP (3 hours), the amputated forelimbs were perfused by a pressure-controlled system through the axillary artery. The perfusion solution consisted of William’s E medium, which was enriched with dexamethasone, insulin and heparin. A venous outflow was prepared for sample collection. Hemodynamics of the limbs was monitored by evaluation of arterial flow and vascular resistance. Perfusion samples were collected at 30 min intervals for biochemical analysis. Lactate clearance was monitored as a marker of muscle injury. Muscle biopsies were collected at 60 min intervals for measurement of ATP production. Results Arterial outflow and vascular resistance remained stable throughout the perfusion, between 270 and 320 mL/min and 0.23 and 0.26 mmHg/mL/min, respectively. Despite the initial increase in lactate levels from 0.2 mmol/L to > 6 mmol/L, this value remained stable during the final hour of perfusion. The increase in ATP production reflects successful resuscitation of the forelimb, increasing from a baseline of 5500 before perfusion to 7500 nmol/g protein during SNMP. Conclusions SNMP has the potential to both actively preserve and enhance overall preservation of forelimbs in a swine model. It may provide the crucial enabling technology for tissue preservation, transport, and eventual transplantation of VCAs. CONTACT Alexandre Gaston Lellouch [email protected]